Company Analysis

Tonix Pharmaceuticals Holding Corp. (TNXP)

Nasdaq: TNXP · Pharmaceutical Preparations · Berkeley Heights, NJ · filing with the SEC since 2008
Grade4.6
◀ Past 3.4● Present 5.3▶ Future 4.6
2 est.

Who runs Tonix Pharmaceuticals Holding Corp.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Lederman Seth
Chief Executive Officer. First filing Jan 2013, latest Nov 12, 2026, 30 filings in all.
Officers reporting now
6
of 14 people with a filing in the last fifteen months
Directors reporting now
8
23 people on the record since 2013
Officerssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Lederman SethChief Executive OfficerJan 2013Nov 12, 2026none
Englese ThomasChief Commercial OfficerSep 2026Sep 8, 2026none
Saenger BradleyChief Financial OfficerFeb 2016Jul 9, 2026none
Morris Jessica EdgarChief Operating OfficerOct 2015Feb 26, 2026none
Fogarty SiobhanChief Technology OfficerFeb 2025Feb 26, 2026none
Sullivan Gregory MChief Medical OfficerJun 2014Feb 26, 2026none
Directorssales are open-market, Nov 12, 2025 to Nov 12, 2026
NameRoleFirst filingLatest filingSales, 12 months
Bagger Richard HdirectorJun 2020Aug 24, 2026none
Taylor Carolyn E.directorJul 2021Jun 15, 2026none
Stillwell Richard NewcombdirectorMar 2023Jun 9, 2026none
Bell Margaret SmithdirectorSep 2017May 14, 2026none
Grange David LdirectorFeb 2018May 14, 2026none
Hunter James Randolph JrdirectorJun 2025May 14, 2026none
Olukotun Adeoye YdirectorSep 2018May 14, 2026none
Treco JamesdirectorFeb 2019May 14, 2026none
Earlier names on the record9, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton TNXP · research, not advice